Research map: Contextual Factors Affecting SGLT2 Inhibitors and GLP ‐1 Receptor Agonists Prescribing in Primary Care: An Application of the Consolidated Framework for Implementation Research

Back to the article

Papers in this map

  1. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups · Allison Tong · 2007 · 44097 citations · Cited by this paper
  2. Prescribing Caution: A Critique of OpenEvidence to Answer Medication‐Related Questions · 2026 · Related
  3. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science · Laura J. Damschroder · 2009 · 15462 citations · Cited by this paper
  4. Comparison of Large Language Model‐Based Systems and Prompt Engineering for Internal Medicine Clinical Pharmacy Cases · 2026 · Related
  5. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  6. Comparison of Drug Information Questions' Responses Between Drug Information Pharmacists and Artificial Intelligence Technologies: A Real‐World Analysis in a Tertiary Care Hospital · 2026 · Related
  7. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction · John J.V. McMurray · 2019 · 7146 citations · Cited by this paper
  8. Clinical Pharmacists in Primary Care: A Real‐World Experience From São Paulo, Brazil · 2026 · Related
  9. The updated Consolidated Framework for Implementation Research based on user feedback · Laura J. Damschroder · 2022 · 4381 citations · Cited by this paper
  10. Practical Applications of Artificial Intelligence in Clinical Pharmacy Practice and Education: Opportunities, Challenges, and a Path Forward · 2026 · Related
  11. A simple method to assess and report thematic saturation in qualitative research · Greg Guest · 2020 · 2916 citations · Cited by this paper
  12. Using an Ambient Artificial Intelligence Tool to Document Clinical Pharmacist Patient Encounters: Real‐World Evidence From a Federally Qualified Health Center · 2026 · Related
  13. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis · Brendon Lange Neuen · 2019 · 893 citations · Cited by this paper
  14. Comment on “ ACCP Position Statement on Direct‐to‐Consumer Advertising of Prescription Medications” · 2026 · Related
  15. Determinants of patient adherence: a review of systematic reviews · Przemysław Kardas · 2013 · 817 citations · Cited by this paper
  16. From Awareness to Action: Increasing Health Equity by Addressing Cultural and Structural Barriers in Pharmacy Practice, Education, and Research · 2026 · Related
  17. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes · Pantelis A. Sarafidis · 2016 · 711 citations · Cited by this paper
  18. Research and Scholarly Methods: Using Theory, Models, and Frameworks to Guide Study Design · 2026 · Related
  19. Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes · Melanie J. Davies · 2017 · 501 citations · Cited by this paper
  20. Reasons For Physicians Not Adopting Clinical Decision Support Systems: Critical Analysis · Saif Sherif Khairat · 2018 · 376 citations · Cited by this paper
  21. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus · Juan José Gorgojo Martínez · 2022 · 340 citations · Cited by this paper
  22. Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review · Bruno Rushforth · 2016 · 312 citations · Cited by this paper
  23. A Randomized Trial of Electronic Clinical Reminders to Improve Quality of Care for Diabetes and Coronary Artery Disease · Thomas Dean Sequist · 2005 · 263 citations · Cited by this paper
  24. Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin · Michael Leo Parchman · 2007 · 208 citations · Cited by this paper
  25. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials · Sarah Pousinho · 2016 · 204 citations · Cited by this paper
  26. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis · Bobby Presley · 2018 · 182 citations · Cited by this paper
  27. National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 · Rishav Adhikari · 2022 · 167 citations · Cited by this paper
  28. Team-Based Care to Improve Diabetes Management: A Community Guide Meta-analysis · Timothy W. Levengood · 2019 · 111 citations · Cited by this paper
  29. Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program · Jing Luo · 2020 · 100 citations · Cited by this paper
  30. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 · Mandeep Singh Bajaj · 2025 · 91 citations · Cited by this paper
  31. First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists · Jin Choi · 2022 · 85 citations · Cited by this paper
  32. Encounters by Patients With Type 2 Diabetes--Complex and Demanding: An Observational Study · Michael Leo Parchman · 2006 · 84 citations · Cited by this paper
  33. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials · Sunya‐Lee Antoine · 2014 · 82 citations · Cited by this paper
  34. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease · Jing Luo · 2023 · 75 citations · Cited by this paper
  35. Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes · Utibe R. Essien · 2023 · 66 citations · Cited by this paper
  36. Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus · Arash Aghajani Nargesi · 2021 · 64 citations · Cited by this paper
  37. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists · Muthiah Vaduganathan · 2019 · 58 citations · Cited by this paper
  38. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome · Chiadi E. Ndumele · 2026 · 52 citations · Cited by this paper
  39. Pharmacists improve diabetes outcomes: a randomized controlled trial · Mary Wagner · 2021 · 19 citations · Cited by this paper

Source: OpenAlex (CC0)